Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer
Clinical trial NCT02358161 · COMPLETED
Trial details
- NCT number
- NCT02358161
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2018-09-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.